Sildenafil Citrate Tablet, Film Coated
Product Images NDC 68071-3549

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 68071-3549). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3549 5)

Label for Sildenafil 100 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The label shows the product name, strength, and count of 15 tablets. Tablets are described as oval, green, debossed with '100' on the obverse and 'SC' on the reverse. Includes warnings to keep out of reach of children and storage instructions at 68-77°F. Manufacturer information and multiple barcodes are also visible.*

FDA Label Image

Sildenafil_fig1.jpg (Sildenafil Fig1)

Line graph showing the mean change from baseline in sitting systolic blood pressure over 24 hours in healthy volunteers, comparing Sildenafil 100 mg and placebo. The x-axis represents time post dose in hours, and the y-axis represents the change in systolic blood pressure (mmHg).*

FDA Label Image

Sildenafil_fig3 (Sildenafil Fig 3)

A line graph depicting the mean standing systolic blood pressure change from baseline over time (hours) postdose. Two treatment groups are shown: Doxazosin + Placebo and Doxazosin + Sildenafil 50 mg, with values plotted from 0 to 8 hours postdose.*

FDA Label Image

Sildenafil_fig_4 (Sildenafil Fig 4)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' showing changes in mmHg over time in hours after dosing (0 to 8 hours). It compares two groups: one receiving Doxazosin + Sildenafil 100 mg and the other Doxazosin + Placebo. The y-axis represents the change in blood pressure, ranging from -50 to +40 mmHg, with both lines trending downward initially and then stabilizing.*

FDA Label Image

Sidenafil_fig_5 (Sildenafil Fig 5)

A line graph titled 'Mean Sildenafil Plasma Concentrations in Healthy Male Volunteers' showing plasma concentration (ng/ml) on the y-axis versus time post dose (hours) on the x-axis. The graph depicts the plasma concentration profile of Sildenafil after administration of a commercial tablet dose, with values peaking early and declining gradually over 24 hours.*

FDA Label Image

Sildenafil-fig7 (Sildenafil Fig7)

A vertical bar graph showing the percentage of patients reporting improved erections for different treatments. The x-axis categorizes treatment groups: Placebo (n=463), Sildenafil Tablets 25 mg (n=214), Sildenafil Tablets 50 mg (n=391), and Sildenafil Tablets 100 mg (n=380). The y-axis represents the percentage reporting improvement, with values increasing from Placebo at 24% to 100 mg Sildenafil Tablets at 82%.*

FDA Label Image

Str (Sildenafil Structure)

Chemical structure diagram of sildenafil, the active ingredient in Sildenafil Citrate 100 mg oral tablets by NuCare Pharmaceuticals, Inc. The diagram shows the molecular arrangement with labeled atoms and bonds.*

FDA Label Image

Figure2 (Sildenafil Fig2)

A line graph comparing the change in EDP (mmHg) over time postdose (hours) between two groups: Doxazosin plus Placebo and Doxazosin plus Sildenafil 25 mg. The graph includes data points plotted for each group over an 8-hour period, showing trends in blood pressure changes.*

FDA Label Image

Sildenafil_fig6b (Sildenafil Fig6b)

A bar chart depicting the percentage of patients at endpoint across baseline scores ranging from 0 to 5. Multiple bars per baseline score indicate different patient groups or conditions, with percentages shown on the vertical axis and baseline scores on the horizontal axis.*

FDA Label Image

Sildenafil_fig6a (Sildenafil Figure6a)

A bar chart showing the percentage of patients at endpoint across different baseline scores from 0 to 5. Multiple vertical bars represent various unspecified categories or groups for each baseline score, with a legend on the right indicating different categories.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.